FDA Advisory Panel Votes to Loosen Peptide Restrictions

5 sources covered this ⚠ Left-only compare →

STAT’s coverage frames the vote as a “win for RFK Jr.” and highlights the narrow margin of the decision, while CBS News emphasizes the policy shift, leading with “loosening restrictions” and describing the peptides as “short chains of…

Jul 24, 2026 · 4:28 PM UTC · 0 reactions · 0 comments · 2 views

FDA Advisory Panel Votes to Loosen Peptide Restrictions

On Thursday, an FDA advisory committee recommended easing restrictions on several peptides popular with wellness influencers and celebrities. The panelists voted in favor of putting the peptides on the FDA’s list of substances considered safe for pharmacy compounding. If the FDA follows that advice, telehealth companies are expected to ramp up marketing of the chemicals for wellness and cosmetic uses.

How this story was covered

3 outlets in our directory ran this story, first to last over 32 hours. Coverage spans 2 points on the political spectrum — 1 lean left, 1 centre.

Lean left · 1Centre · 1

▪ FDA panel considers loosening regulations on certain unapproved peptides — CBS News — Top
▪ STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides — STAT

About this source

NBC News — Health files mainly under health. We currently carry 20 of its stories.

All NBC News — Health coverage →

Original article

NBC News Health

Read full at NBC News Health →

Anonymous · no account needed

Discussion

0 comments

FDA Advisory Panel Votes to Loosen Peptide Restrictions

Discussion

More from NBC News Health